These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 2991238)
21. Isolation and partial purification of a new class of transforming growth factors from an avian sarcoma virus-transformed rat cell line. Hirai R; Yamaoka K; Mitsui H Cancer Res; 1983 Dec; 43(12 Pt 1):5742-6. PubMed ID: 6315215 [TBL] [Abstract][Full Text] [Related]
22. Isolation of EGF-dependent transforming growth factor (TGF beta-like) activity from culture medium conditioned by fetal rat calvariae. Centrella M; Canalis E J Bone Miner Res; 1987 Feb; 2(1):29-36. PubMed ID: 3502665 [TBL] [Abstract][Full Text] [Related]
23. Urinary TGFs1 in neoplasia: immunoreactive TGF-alpha in the urine of patients with disseminated breast carcinoma. Stromberg K; Hudgins WR; Orth DN Biochem Biophys Res Commun; 1987 Apr; 144(2):1059-68. PubMed ID: 3472521 [TBL] [Abstract][Full Text] [Related]
24. New class of transforming growth factors potentiated by epidermal growth factor: isolation from non-neoplastic tissues. Roberts AB; Anzano MA; Lamb LC; Smith JM; Sporn MB Proc Natl Acad Sci U S A; 1981 Sep; 78(9):5339-43. PubMed ID: 6975480 [TBL] [Abstract][Full Text] [Related]
25. Transforming growth factor-beta and retinoic acid modulate phenotypic transformation of normal rat kidney cells induced by epidermal growth factor and platelet-derived growth factor. van Zoelen EJ; van Oostwaard TM; de Laat SW J Biol Chem; 1986 Apr; 261(11):5003-9. PubMed ID: 3007486 [TBL] [Abstract][Full Text] [Related]
26. Purification and properties of a type beta transforming growth factor from bovine kidney. Roberts AB; Anzano MA; Meyers CA; Wideman J; Blacher R; Pan YC; Stein S; Lehrman SR; Smith JM; Lamb LC Biochemistry; 1983 Dec; 22(25):5692-8. PubMed ID: 6607069 [TBL] [Abstract][Full Text] [Related]
27. Sarcoma growth factor from conditioned medium of virally transformed cells is composed of both type alpha and type beta transforming growth factors. Anzano MA; Roberts AB; Smith JM; Sporn MB; De Larco JE Proc Natl Acad Sci U S A; 1983 Oct; 80(20):6264-8. PubMed ID: 6604914 [TBL] [Abstract][Full Text] [Related]
28. Epidermal growth factor-like transforming growth factor. II. Interaction with epidermal growth factor receptors in human placenta membranes and A431 cells. Massagué J J Biol Chem; 1983 Nov; 258(22):13614-20. PubMed ID: 6315706 [TBL] [Abstract][Full Text] [Related]
29. Affinity labeling of a transforming growth factor receptor that does not interact with epidermal growth factor. Massague J; Czech MP; Iwata K; DeLarco JE; Todaro GJ Proc Natl Acad Sci U S A; 1982 Nov; 79(22):6822-6. PubMed ID: 6294655 [TBL] [Abstract][Full Text] [Related]
30. Ectopic peptides released by a human melanoma cell line that modulate the transformed phenotype. De Larco JE; Pigott DA Ciba Found Symp; 1985; 116():224-40. PubMed ID: 3000706 [TBL] [Abstract][Full Text] [Related]
31. Variant forms of rat epidermal growth factor present in the urine of nude rats bearing human tumors. Hudgins WR; Orth DN; Stromberg K Cancer Res; 1988 Mar; 48(6):1428-34. PubMed ID: 3257897 [TBL] [Abstract][Full Text] [Related]
32. Synergistic interaction of two classes of transforming growth factors from murine sarcoma cells. Anzano MA; Roberts AB; Meyers CA; Komoriya A; Lamb LC; Smith JM; Sporn MB Cancer Res; 1982 Nov; 42(11):4776-8. PubMed ID: 6290046 [TBL] [Abstract][Full Text] [Related]
33. Transforming growth factors in solid human malignant neoplasms. Nickell KA; Halper J; Moses HL Cancer Res; 1983 May; 43(5):1966-71. PubMed ID: 6299535 [TBL] [Abstract][Full Text] [Related]
35. Transforming growth factors from neoplastic and nonneoplastic tissues. Roberts AB; Frolik CA; Anzano MA; Sporn MB Fed Proc; 1983 Jun; 42(9):2621-6. PubMed ID: 6303865 [TBL] [Abstract][Full Text] [Related]
36. Tumour progression in experimental oral carcinogenesis is associated with changes in EGF and TGF-beta receptor expression and altered responses to these growth factors. Game SM; Stone A; Scully C; Prime SS Carcinogenesis; 1990 Jun; 11(6):965-73. PubMed ID: 2161297 [TBL] [Abstract][Full Text] [Related]
37. Purification of the enhancing factor from mouse intestines. Mulherkar R; Saraf A; Wagle A; Deo MG FEBS Lett; 1986 Oct; 207(1):142-4. PubMed ID: 3490399 [TBL] [Abstract][Full Text] [Related]
38. Characterization of a membrane receptor for transforming growth factor-beta in normal rat kidney fibroblasts. Frolik CA; Wakefield LM; Smith DM; Sporn MB J Biol Chem; 1984 Sep; 259(17):10995-1000. PubMed ID: 6088525 [TBL] [Abstract][Full Text] [Related]
39. Loss of growth responsiveness to epidermal growth factor and enhanced production of alpha-transforming growth factors in ras-transformed mouse mammary epithelial cells. Salomon DS; Perroteau I; Kidwell WR; Tam J; Derynck R J Cell Physiol; 1987 Mar; 130(3):397-409. PubMed ID: 3494020 [TBL] [Abstract][Full Text] [Related]
40. Type beta transforming growth factor from feline sarcoma virus-transformed rat cells. Isolation and biological properties. Massagué J J Biol Chem; 1984 Aug; 259(15):9756-61. PubMed ID: 6086646 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]